Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Peregrine Pharma New (PPHM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 207,322
  • Shares Outstanding, K 45,070
  • Annual Sales, $ 57,630 K
  • Annual Income, $ -28,160 K
  • 36-Month Beta 2.53
  • Price/Sales 4.08
  • Price/Cash Flow 0.00
  • Price/Book 4.14

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.50 +31.43%
on 07/07/17
5.78 -20.42%
on 07/14/17
+0.54 (+13.30%)
since 06/21/17
3-Month
3.50 +31.43%
on 07/07/17
5.78 -20.42%
on 07/14/17
+0.47 (+11.38%)
since 04/21/17
52-Week
1.96 +134.69%
on 01/30/17
5.78 -20.42%
on 07/14/17
+1.94 (+72.93%)
since 07/21/16

Most Recent Stories

More News
Featured Company News - Amgen Submits Regulatory Applications in US, Europe to Include Overall Survival Data in KYPROLIS Label

Research Desk Line-up: Peregrine Pharma Post Earnings Coverage

PPHM : 4.60 (-11.88%)
AMGN : 180.21 (+0.50%)
Today's Research Reports on Trending Tickers: Peregrine Pharmaceuticals and Westport Fuel Systems

NEW YORK, NY / ACCESSWIRE / July 17, 2017 / U.S. markets continued to hit record highs Friday as the potential for a rate hike by the Federal Reserve dimmed on weak economic data. The Dow Jones Industrial...

PPHM : 4.60 (-11.88%)
WPRT : 1.62 (-1.82%)
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent Developments

-- Avid Achieves Year-Over-Year Topline Revenue Growth of 30% Exceeding $57 Million --

PPHM : 4.60 (-11.88%)
PPHMP : 21.70 (-0.87%)
Peregrine to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2017 After Market Close on July 14, 2017

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical...

PPHM : 4.60 (-11.88%)
PPHMP : 21.70 (-0.87%)
Technical Insights on Biotech Stocks -- Idera Pharma, Pieris Pharma, Peregrine Pharma, and Ritter Pharma

If you want a Stock Review on IDRA, PIRS, PPHM or RTTR then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, benchmark US indices were in...

PPHM : 4.60 (-11.88%)
RTTR : 0.57 (+6.94%)
IDRA : 1.88 (-1.05%)
PIRS : 5.70 (+0.88%)
Peregrine Pharmaceuticals Presents Preliminary Correlative Analysis of PD-L1 Expression from SUNRISE Trial at ASCO 2017

-- Negative PD-L1 Expression was Associated with a Significantly Longer Median Overall Survival Compared to Positive PD-L1 Expression in Patients Receiving Docetaxel Plus Bavituximab --

PPHM : 4.60 (-11.88%)
PPHMP : 21.70 (-0.87%)
Biotech Stocks Under Scanner -- Rexahn Pharma, Peregrine Pharma, Immunomedics, and Protalix BioTherapeutics

Stock-Callers.com has issued research reports on these following stocks: Rexahn Pharmaceuticals Inc. (NYSE MKT: RNN), Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM), Immunomedics Inc. (NASDAQ: IMMU), and...

PPHM : 4.60 (-11.88%)
RNN : 2.27 (+0.89%)
PLX : 0.74 (-2.63%)
IMMU : 8.66 (+0.46%)
Implied Volatility Surging for Peregrine Pharmaceuticals (PPHM) Stock Options

Peregrine Pharmaceuticals (PPHM) warrants investors' attention based on moves in the options market lately.

PPHM : 4.60 (-11.88%)
MilliporeSigma's Mobius(R) 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities

Technology allows Avid to meet increased demand for clinical and commercial manufacturing services at Myford facility

PPHM : 4.60 (-11.88%)
PPHMP : 21.70 (-0.87%)
MilliporeSigma's Mobius(R) 2,000-liter Single-use Bioreactors to Expand Avid Bioservices' Manufacturing Capabilities

Technology allows Avid to meet increased demand for clinical and commercial manufacturing services at Myford facility

PPHM : 4.60 (-11.88%)
PPHMP : 21.70 (-0.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators mostly agree with the trend.

See More

Business Summary

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus infection. The company is pursuing three separate clinical trials in cancer and HCV infection with its lead product candidate...

See More

Support & Resistance

2nd Resistance Point 5.58
1st Resistance Point 5.09
Last Price 4.60
1st Support Level 4.28
2nd Support Level 3.96

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.